perinatologyРоссийский вестник перинатологии и педиатрииRossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)1027-40652500-2228Ltd. “The National Academy of Pediatric Science and Innovation”perinatology-133Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWSПробиотики в профилактике атопического дерматита и пищевой аллергии у детейProbiotics in the prevention of atopic dermatitis and food allergy in childrenКасихинаЕ. И.KasikhinaE. I.

к.м.н., доц. каф. дерматовенерологии, микологии и косметологии Учебно-научного медицинского центра Управления делами Президента РФ 121359 Москва, ул. Маршала Тимошенко, д. 21

ФГБУ «Учебно-научный медицинский центр» Управления делами Президента РФ, МоскваРоссияTraining and Research Medical Center, Department for Presidential Affairs of the Russian Federation, MoscowRussian Federation2015130320166043743Copyright © Ltd. “The National Academy of Pediatric Science and Innovation”, 20162016Ltd. “The National Academy of Pediatric Science and Innovation”Ltd. “The National Academy of Pediatric Science and Innovation”https://www.ped-perinatology.ru/jour/about/submissions#copyrightNoticehttps://www.ped-perinatology.ru/jour/article/view/133

Обзор посвящен актуальной междисциплинарной проблеме — профилактике атопических заболеваний, в которой немаловажную роль играют пробиотические препараты. Анализ клинических катамнестических исследований экспертами показал, что назначение данных препаратов беременным женщинам и новорожденным достоверно уменьшает риск развития атопического дерматита.

The review deals with the relevant interdisciplinary problem - to prevent atopic diseases, in which probiotics play an important role. Analysis of clinical follow-up studies has shown that the use of these drugs in pregnant women and newborns significantly reduces the risk of atopic dermatitis.

детиатонический дерматитпробиотикиЛинекс®.childrenatopic dermatitisprobioticsLinex®.ReferencesЗахарова И.Н., Дмитриева Ю.А. Особенности становления кишечной микрофлоры у детей раннего возраста. Педиатрия 2014; 6: 138—144. (Zakharova I.N., Dmitriye-va Yu.A. Features of formation of intestinal microflora at children of early age. Pediatrija2014; 6: 138-144.)Захарова И.Н., Дмитриева Ю.А. Особенности становления кишечной микрофлоры у детей раннего возраста. Педиатрия 2014; 6: 138—144. (Zakharova I.N., Dmitriye-va Yu.A. Features of formation of intestinal microflora at children of early age. Pediatrija2014; 6: 138-144.)Yatsunenko Т., Rey F.E., Manary M.J. et al. Human gut mi-crobiome viewed across age and geography. Nature 2012; 486: 222-227.Yatsunenko Т., Rey F.E., Manary M.J. et al. Human gut mi-crobiome viewed across age and geography. Nature 2012; 486: 222-227.Dominguez-Bello M.G., CostelloE.K., ContrerasM. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc NatlAcadSci USA 2010; 107: 11971-11975.Dominguez-Bello M.G., CostelloE.K., ContrerasM. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc NatlAcadSci USA 2010; 107: 11971-11975.Thavagnanam S., Fleming J., Bromley A. et al. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy 2008; 38: 629-633.Thavagnanam S., Fleming J., Bromley A. et al. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy 2008; 38: 629-633.Penders J., Thijs C, van den Brandt P.A. et al. Gut micro-biota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56: 661-667.Penders J., Thijs C, van den Brandt P.A. et al. Gut micro-biota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56: 661-667.Olszak Т., An D., Zeissig S. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489-493.Olszak Т., An D., Zeissig S. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489-493.Bjorksten В., Sepp E., Julge K. et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516-520.Bjorksten В., Sepp E., Julge K. et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516-520.Bottcher M.F., Nordin E.K., Sandin A. et al. Microflora-asso-ciated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30: 1590-1596.Bottcher M.F., Nordin E.K., Sandin A. et al. Microflora-asso-ciated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30: 1590-1596.Strachan D.P. Hay fever, hygiene, and household size. Br Med J 1989; 299: 1259-1260.Strachan D.P. Hay fever, hygiene, and household size. Br Med J 1989; 299: 1259-1260.Strachan D.P. Family size, infection and atopy: the first decade of the «hygiene hypothesis». Thorax 2000; 55: 1: 2—10.Strachan D.P. Family size, infection and atopy: the first decade of the «hygiene hypothesis». Thorax 2000; 55: 1: 2—10.Pelucchi C, Chatenoud L., Turati F. et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23: 402-414.Pelucchi C, Chatenoud L., Turati F. et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23: 402-414.Eisenbarth S.C., Piggott D.A., Huleatt J.W. et al. Lipopolysac-charide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.Eisenbarth S.C., Piggott D.A., Huleatt J.W. et al. Lipopolysac-charide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.Perz.anowski M.S., Miller R.L., Thome P.S. et al. Endotoxin in inner-city homes: associations with wheeze and eczema in early childhood. J Allergy Clin Immunol 2006; 117: 1082-1089.Perz.anowski M.S., Miller R.L., Thome P.S. et al. Endotoxin in inner-city homes: associations with wheeze and eczema in early childhood. J Allergy Clin Immunol 2006; 117: 1082-1089.Isolauri E., Arvola Т., Sutas Y. et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-1610.Isolauri E., Arvola Т., Sutas Y. et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-1610.Feleszko W., Jaworska J., Rha R.D. et al. Probiotic-induced suppression of allergic sensitizationand airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007; 37: 498—505.Feleszko W., Jaworska J., Rha R.D. et al. Probiotic-induced suppression of allergic sensitizationand airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007; 37: 498—505.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 2001; 357: 1076-1079.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 2001; 357: 1076-1079.Sepp E., Julge K., Mikelsaar M.etal. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005; 35: 1141-1146.Sepp E., Julge K., Mikelsaar M.etal. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005; 35: 1141-1146.Salminen S., Von Wright A., Morelli L., Marteau P. Demonstration of safety of probiotics — a review. Int J Food Micro-biol 1998; 44: 93-106.Salminen S., Von Wright A., Morelli L., Marteau P. Demonstration of safety of probiotics — a review. Int J Food Micro-biol 1998; 44: 93-106.Salminen S., Bouley C, Boutron-Ruault M. C. et al. Functional food science and gastrointestinal physiology and function. Br JNutrl998; 80: 1: 147-171.Salminen S., Bouley C, Boutron-Ruault M. C. et al. Functional food science and gastrointestinal physiology and function. Br JNutrl998; 80: 1: 147-171.Захаренко СМ. Иммунотропные эффекты пробиотиков. Инфекционные болезни 2014; 12: 1: 71—80. (Zakharen-ko S. М. Immunotropic effects of probiotics. Infekcionnye bolezni2014; 12: 1:71-80.)Захаренко СМ. Иммунотропные эффекты пробиотиков. Инфекционные болезни 2014; 12: 1: 71—80. (Zakharen-ko S. М. Immunotropic effects of probiotics. Infekcionnye bolezni2014; 12: 1:71-80.)Havenaar R. and Huis in't Veld J. Probiotics: a general view. In: B.J. Wood (ed.) The lactic acid bacteria Vol. 1. The lactic acid bacteria in health and disease. Chapman and Hall, New York, NY, USA 1992; 209-224.Havenaar R. and Huis in't Veld J. Probiotics: a general view. In: B.J. Wood (ed.) The lactic acid bacteria Vol. 1. The lactic acid bacteria in health and disease. Chapman and Hall, New York, NY, USA 1992; 209-224.FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 2006; 88:1—36.FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 2006; 88:1—36.Касихина Е.И. Возможности использования комплекса пробиотических штаммов с микроэлементами в дерматовенерологии. Врач 2014; 12: 17—21. (Kasikhina E.I. Possibilities of use of a complex of pro-biotic strains with micro-cells in a dermatovenereology. Vrach 2014; 12: 17—21.)Касихина Е.И. Возможности использования комплекса пробиотических штаммов с микроэлементами в дерматовенерологии. Врач 2014; 12: 17—21. (Kasikhina E.I. Possibilities of use of a complex of pro-biotic strains with micro-cells in a dermatovenereology. Vrach 2014; 12: 17—21.)Folster-Holst R. Probiotics in the treatment and prevention of atopic dermatitis. AnnNutrit Metabol 2010; 57: 16-19.Folster-Holst R. Probiotics in the treatment and prevention of atopic dermatitis. AnnNutrit Metabol 2010; 57: 16-19.Gruber C, Van Stuijvenberg M., Mosca F. and the MIPS1 Working Group. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010; 126: 791-797.Gruber C, Van Stuijvenberg M., Mosca F. and the MIPS1 Working Group. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010; 126: 791-797.Kim H.J., Kim H. Y, Lee S. Y. et al. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J Pediat 2013; 56: 9: 369-376.Kim H.J., Kim H. Y, Lee S. Y. et al. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J Pediat 2013; 56: 9: 369-376.Abrahamsson T.R., Jakobsson Т., Bottcher M.F. et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119: 1174-1180.Abrahamsson T.R., Jakobsson Т., Bottcher M.F. et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119: 1174-1180.Kukkonen K, Savilahti E., Haahtela T. et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 192-198.Kukkonen K, Savilahti E., Haahtela T. et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 192-198.Kim N.Y., Ji G.E. Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediat 2012; 55: 193-201.Kim N.Y., Ji G.E. Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediat 2012; 55: 193-201.Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-121.Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-121.Arslanoglu S., Mom G.E., Schmitt J. et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutrit 2008; 138: 1091-1095.Arslanoglu S., Mom G.E., Schmitt J. et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutrit 2008; 138: 1091-1095.Arslanoglu S., Mom G.E., Boehm G. et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 2012; 26: 49-59.Arslanoglu S., Mom G.E., Boehm G. et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 2012; 26: 49-59.Dotterud C.K, Storm O., Johnsen R., Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163: 616-623.Dotterud C.K, Storm O., Johnsen R., Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163: 616-623.Kim J.Y., Kwon, J.H., Ahn, S.H. et al. Effect of probiotic mix (Bifidobacteriumbifidum, Bifidobacteriumlactis, Lactobacil-lus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebocontrolled trial. Pediat Allergy Immunol 2010; 21: 386-393.Kim J.Y., Kwon, J.H., Ahn, S.H. et al. Effect of probiotic mix (Bifidobacteriumbifidum, Bifidobacteriumlactis, Lactobacil-lus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebocontrolled trial. Pediat Allergy Immunol 2010; 21: 386-393.Kalliomaki M., Salminen S., Poussa T. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. The Lancet 2003; 361: 1869-1871.Kalliomaki M., Salminen S., Poussa T. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. The Lancet 2003; 361: 1869-1871.Wickens K, Black P.N., Stanley T. V. et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122:788-794.Wickens K, Black P.N., Stanley T. V. et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122:788-794.Dotterud C.K, Storm O., Johnsen R. et al. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. BrJ Dermatol 2010; 163: 616-623.Dotterud C.K, Storm O., Johnsen R. et al. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. BrJ Dermatol 2010; 163: 616-623.GerasimovS.V., Vasjuta V.V., Myhovych O.O.,BondarchukL.L Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010; 11: 351-361.GerasimovS.V., Vasjuta V.V., Myhovych O.O.,BondarchukL.L Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010; 11: 351-361.Kirjavainen P.V., Salminen S.J., LsolauriE. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediat Gastroenterol Nutr 2003; 36: 223-227.Kirjavainen P.V., Salminen S.J., LsolauriE. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediat Gastroenterol Nutr 2003; 36: 223-227.Majamaa H., Lsolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:2:179-185.Majamaa H., Lsolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:2:179-185.Kalliomaki M., Salminen S., Poussa Т., Lsolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021.Kalliomaki M., Salminen S., Poussa Т., Lsolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021.RU1508371270RU1508371270Николаева СВ. Роль молочнокислых бактерий в здоровье человека. Лечащий врач 2013; 2: 78—80. (Nikolaeva S. V. Role of lactic bacteria in health of the person. Lechashii vrach 2013; 2: 78-80.)Николаева СВ. Роль молочнокислых бактерий в здоровье человека. Лечащий врач 2013; 2: 78—80. (Nikolaeva S. V. Role of lactic bacteria in health of the person. Lechashii vrach 2013; 2: 78-80.)Циколия Э.М. Клиническая фармакология Линекса®. Международный Журнал прикладных и фундаментальных исследований 2013; 8: 106—107. (Tsikoliya E.M. Clinical Lineks's pharmacology. Mezhdunarodnyi Zhurnal prikladnyhifundamental'nyhissledovanii2013; 8: 106—107.)Циколия Э.М. Клиническая фармакология Линекса®. Международный Журнал прикладных и фундаментальных исследований 2013; 8: 106—107. (Tsikoliya E.M. Clinical Lineks's pharmacology. Mezhdunarodnyi Zhurnal prikladnyhifundamental'nyhissledovanii2013; 8: 106—107.)Шевяков М.А. Пробиотики и профилактика аллергии. Вопр практ педиат 2012; 7: 2: 2—6. (Shevyakov M. A. Probiotics and prevention of an allergy, fopr prakt pediat 2012; 7: 2:2—6.)Шевяков М.А. Пробиотики и профилактика аллергии. Вопр практ педиат 2012; 7: 2: 2—6. (Shevyakov M. A. Probiotics and prevention of an allergy, fopr prakt pediat 2012; 7: 2:2—6.)Klebanoff S.J., Coombs R.W. Viricidal effect of Lactobacfflus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991; 174: 1: 289-292.Klebanoff S.J., Coombs R.W. Viricidal effect of Lactobacfflus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991; 174: 1: 289-292.Christensen H.R., Larsen C.N., Kstel P. et al. Immunomodu-lating potential of supplementation with probiotics: a dose response study in healthy young adults. FEMS Immunol Med Microbiol 2006; 47: 380-390.Christensen H.R., Larsen C.N., Kstel P. et al. Immunomodu-lating potential of supplementation with probiotics: a dose response study in healthy young adults. FEMS Immunol Med Microbiol 2006; 47: 380-390.OuwehandA. С Antiallergic Effects of Probiotics. J Nutr 2007; 137: 794-797.OuwehandA. С Antiallergic Effects of Probiotics. J Nutr 2007; 137: 794-797.Kirjavainen P.V., Arvola Т., Salminen S.J., Lsolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Downloaded from http://gut.bmj.com/ on May 19, 2015 — Published by group. bmj.com.Kirjavainen P.V., Arvola Т., Salminen S.J., Lsolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Downloaded from http://gut.bmj.com/ on May 19, 2015 — Published by group. bmj.com.Fiocchi A. Pawankaret R., Cuello-Garcia С et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organization J 2015; 8: 4-17.Fiocchi A. Pawankaret R., Cuello-Garcia С et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organization J 2015; 8: 4-17.Dang D., Zhou W., Lun Z. et al. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J Int Med Res 2013; 41: 5: 1426-1436.Dang D., Zhou W., Lun Z. et al. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J Int Med Res 2013; 41: 5: 1426-1436.West C, LLammarstrom M., Hernell O. Probiotics in primary prevention of allergic disease—follow-up at 8-9 years of age. Allergy 2013; 68: 8: 1015-1020.West C, LLammarstrom M., Hernell O. Probiotics in primary prevention of allergic disease—follow-up at 8-9 years of age. Allergy 2013; 68: 8: 1015-1020.Toh Z., Anzela A., Tang M. et al. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol 2012; 3: 171.Toh Z., Anzela A., Tang M. et al. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol 2012; 3: 171.FoisyM., Boyle R., Chalmers J. et al. Overview of Reviews The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid Based Child Health 2011; 6: 5: 1322-1339.FoisyM., Boyle R., Chalmers J. et al. Overview of Reviews The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid Based Child Health 2011; 6: 5: 1322-1339.Kim LL., KwackK, Kim D.Y., Ji G.E. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol Med Microbiol 2005; 45: 259-267.Kim LL., KwackK, Kim D.Y., Ji G.E. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol Med Microbiol 2005; 45: 259-267.CastellazziA.M., Valsecchi C, CaimmiS. et al. Probiotics and food allergy. Ital J Pediat 2013; 39: 47.CastellazziA.M., Valsecchi C, CaimmiS. et al. Probiotics and food allergy. Ital J Pediat 2013; 39: 47.Zhang L.L., Chen X., Zheng P.Y. et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 2010; 25: 928-934.Zhang L.L., Chen X., Zheng P.Y. et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 2010; 25: 928-934.Schiavi E., Barletta В., .Butteroni С et al. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy 2011; 66: 499-508.Schiavi E., Barletta В., .Butteroni С et al. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy 2011; 66: 499-508.LLolJ., van Leer E.H., Elink Schuurman B.E. et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol 2008; 121: 1448-1454.LLolJ., van Leer E.H., Elink Schuurman B.E. et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol 2008; 121: 1448-1454.Kaminska E. Effectiveness and safety of probiotics in children on the basis of clinical trials. Medycyna Wieku Rozwojowego 2012; 16: 240-251.Kaminska E. Effectiveness and safety of probiotics in children on the basis of clinical trials. Medycyna Wieku Rozwojowego 2012; 16: 240-251.Berasategui A., Villarejo В., Sanchez C. et al. Potential hiper-sensitivity due to the food or food additive content of medicinal product in Spain. Gudelines. J Inv Allergol Clin Immunol 2011; 21: 496-506.Berasategui A., Villarejo В., Sanchez C. et al. Potential hiper-sensitivity due to the food or food additive content of medicinal product in Spain. Gudelines. J Inv Allergol Clin Immunol 2011; 21: 496-506.

The authors declare that there are no conflicts of interest present.